-
Je něco špatně v tomto záznamu ?
Serine protease inhibitors N-alpha-tosyl-L-lysinyl-chloromethylketone (TLCK) and N-tosyl-L-phenylalaninyl-chloromethylketone (TPCK) do not inhibit caspase-3 and caspase-7 processing in cells exposed to pro-apoptotic inducing stimuli
I Frydrych, P Mlejnek
Jazyk angličtina Země Spojené státy americké
Typ dokumentu práce podpořená grantem
NLK
Wiley Online Library (archiv)
od 1996-01-01 do 2012-12-31
- MeSH
- apoptóza MeSH
- HL-60 buňky MeSH
- inhibitory kaspas MeSH
- inhibitory serinových proteinas farmakologie MeSH
- kaspasa 3 metabolismus MeSH
- kaspasa 7 metabolismus MeSH
- lidé MeSH
- tosylfenylalanylchlormethylketon farmakologie MeSH
- tosyllysinchlormethylketon farmakologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- práce podpořená grantem MeSH
We recently demonstrated that TLCK and TPCK could act as potent but nonspecific inhibitors of mature caspases [Frydrych and Mlejnek [2008] J Cell Biochem 103:1646-1656]. The question whether TLCK and TPCK inhibit simultaneously caspase activation and/or processing remained, however, open. In this article, we demonstrated that TPCK even enhanced caspase-3 and caspase-7 processing although it substantially inhibited caspase-3 and caspase-7 enzymatic (DEVDase) activity in HL-60 cells exposed to various cell death inducing stimuli. Under the same conditions, TLCK had no effect or affected caspase-3 and caspase-7 processing marginally depending on cell treatment used. Importantly, TLCK substantially inhibited caspase-3 and caspase-7 enzymatic (DEVDase) activity irrespectively to the treatment used. Interestingly, treatment of cells with toxic concentrations of TPCK alone was accompanied by full caspase-3 and -7 processing even if it induced necrosis. In contrast, treatment of cells with concentrations of TLCK that caused necrosis was accompanied by only partial caspase-3 and caspase-7 processing. Our results clearly indicated that TPCK and TLCK did not inhibit caspase-3 and -7 enzymatic activity by prevention of their activation and/or processing.
- 000
- 02819naa 2200337 a 4500
- 001
- bmc11006241
- 003
- CZ-PrNML
- 005
- 20121112124307.0
- 008
- 110401s2008 xxu e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Frydrych, Ivo $7 xx0169396
- 245 10
- $a Serine protease inhibitors N-alpha-tosyl-L-lysinyl-chloromethylketone (TLCK) and N-tosyl-L-phenylalaninyl-chloromethylketone (TPCK) do not inhibit caspase-3 and caspase-7 processing in cells exposed to pro-apoptotic inducing stimuli / $c I Frydrych, P Mlejnek
- 314 __
- $a Faculty of Medicine and Dentistry, Department of Biology, Palacky University Olomouc, Hnevotinska 3, Olomouc 77515, Czech Republic.
- 520 9_
- $a We recently demonstrated that TLCK and TPCK could act as potent but nonspecific inhibitors of mature caspases [Frydrych and Mlejnek [2008] J Cell Biochem 103:1646-1656]. The question whether TLCK and TPCK inhibit simultaneously caspase activation and/or processing remained, however, open. In this article, we demonstrated that TPCK even enhanced caspase-3 and caspase-7 processing although it substantially inhibited caspase-3 and caspase-7 enzymatic (DEVDase) activity in HL-60 cells exposed to various cell death inducing stimuli. Under the same conditions, TLCK had no effect or affected caspase-3 and caspase-7 processing marginally depending on cell treatment used. Importantly, TLCK substantially inhibited caspase-3 and caspase-7 enzymatic (DEVDase) activity irrespectively to the treatment used. Interestingly, treatment of cells with toxic concentrations of TPCK alone was accompanied by full caspase-3 and -7 processing even if it induced necrosis. In contrast, treatment of cells with concentrations of TLCK that caused necrosis was accompanied by only partial caspase-3 and caspase-7 processing. Our results clearly indicated that TPCK and TLCK did not inhibit caspase-3 and -7 enzymatic activity by prevention of their activation and/or processing.
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a apoptóza $7 D017209
- 650 _2
- $a kaspasa 3 $x metabolismus $7 D053148
- 650 _2
- $a kaspasa 7 $x metabolismus $7 D053179
- 650 _2
- $a HL-60 buňky $7 D018922
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inhibitory serinových proteinas $x farmakologie $7 D015842
- 650 _2
- $a tosyllysinchlormethylketon $x farmakologie $7 D014107
- 650 _2
- $a tosylfenylalanylchlormethylketon $x farmakologie $7 D014108
- 650 _2
- $a inhibitory kaspas $7 D061945
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Mlejnek, Petr, $d 1963- $7 xx0023808
- 773 0_
- $t Journal of Cellular Biochemistry $w MED00002577 $g Roč. 105, č. 6 (2008), s. 1501-1506
- 910 __
- $a ABA008 $b B 1700 $y 2
- 990 __
- $a 20110414102644 $b ABA008
- 991 __
- $a 20121112124321 $b ABA008
- 999 __
- $a ok $b bmc $g 833848 $s 698333
- BAS __
- $a 3
- BMC __
- $a 2008 $x MED00002577 $b 105 $c 6 $d 1501-1506 $m Journal of cellular biochemistry $n J Cell Biochem
- LZP __
- $a 2011-1B09/dkjp